Evidence map›Paper›PMID 28476069›Full record

ArticleBritish journal of pharmacology2017

ELAC (3,12-di-O-acetyl-8-O-tigloilingol), a plant-derived lathyrane diterpene, induces subventricular zone neural progenitor cell proliferation through PKCβ activation.

Maribel Murillo-Carretero, Noelia Geribaldi-Doldán, Eugenia Flores-Giubi, Francisco García-Bernal, Elkin A Navarro-Quiroz, Manuel Carrasco, Antonio J Macías-Sánchez, Pilar Herrero-Foncubierta, Antonio Delgado-Ariza, Cristina Verástegui and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. CORRECTION.British journal of pharmacology · 2020
    Article
  14. Article
  15. Protein Kinase C: Targets to Regenerate Brain Injuries?Frontiers in cell and developmental biology · 2019
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 2 countries.

Maribel Murillo-CarreteroÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Noelia Geribaldi-DoldánÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Eugenia Flores-GiubiDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Cádiz, Puerto Real, Cádiz, Spain and Instituto de Investigación en Biomoléculas (INBIO).
Francisco García-BernalÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Elkin A Navarro-QuirozÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Manuel CarrascoÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Antonio J Macías-SánchezDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Cádiz, Puerto Real, Cádiz, Spain and Instituto de Investigación en Biomoléculas (INBIO).
Pilar Herrero-FoncubiertaÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Antonio Delgado-ArizaÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Cristina VerásteguiDepartamento de Anatomía y Embriología Humana, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación en Innovación Biomédica de Cádiz (INiBICA).
Jesús Domínguez-RiscartÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).
Mourad DaoubiDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Cádiz, Puerto Real, Cádiz, Spain and Instituto de Investigación en Biomoléculas (INBIO).
Rosario Hernández-GalánDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Cádiz, Puerto Real, Cádiz, Spain and Instituto de Investigación en Biomoléculas (INBIO).
Carmen CastroÁrea de Fisiología, Facultad de Medicina, Universidad de Cádiz, Cádiz, Spain and Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA).ORCID http://orcid.org/0000-0002-6802-0572
Universidad de Cádiz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePharmacological strategies aimed to facilitate neuronal renewal in the adult brain, by promoting endogenous neurogenesis, constitute promising therapeutic options for pathological or traumatic brain lesions. We have previously shown that non-tumour-promoting PKC-activating compounds (12-deoxyphorbols) promote adult neural progenitor cell (NPC) proliferation in vitro and in vivo, enhancing the endogenous neurogenic response of the brain to a traumatic injury. Here, we show for the first time that a diterpene with a lathyrane skeleton can also activate PKC and promote NPC proliferation. EXPERIMENTAL APPROACH: We isolated four lathyranes from the latex of Euphorbia plants and tested their effect on postnatal NPC proliferation, using neurosphere cultures. The bioactive lathyrane ELAC (3,12-di-O-acetyl-8-O-tigloilingol) was also injected into the ventricles of adult mice to analyse its effect on adult NPC proliferation in vivo. KEY

resultsThe lathyrane ELAC activated PKC and significantly increased postnatal NPC proliferation in vitro, particularly in synergy with FGF2. In addition ELAC stimulated proliferation of NPC, specifically affecting undifferentiated transit amplifying cells. The proliferative effect of ELAC was reversed by either the classical/novel PKC inhibitor Gö6850 or the classical PKC inhibitor Gö6976, suggesting that NPC proliferation is promoted in response to activation of classical PKCs, particularly PKCß. ELAC slightly increased the proportion of NPC expressing Sox2. The effects of ELAC disappeared upon acetylation of its C7-hydroxyl group. CONCLUSIONS AND IMPLICATIONS: We propose lathyranes like ELAC as new drug candidates to modulate adult neurogenesis through PKC activation. Functional and structural comparisons between ELAC and phorboids are included.

Indexed as

AnimalsCell ProliferationCells, CulturedCell SurvivalDiterpenesDose-Response Relationship, DrugMiceMolecular ConformationNeural Stem CellsProtein Kinase C betaStructure-Activity RelationshipDiterpeneslathyraneProtein Kinase C beta

Identifiers

PMID28476069
PMCPMC5481651
OpenAlexW2613892492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.